Health Care & Life Sciences » Biotechnology | Cellect Biotechnology Ltd.

Cellect Biotechnology Ltd.

Cellect Biotechnology Ltd. ADR
Stock Exchange NASDAQ Stock Market
EPS
$0.86
Market Cap
$3.03 M
Shares Outstanding
5.6 M
Public Float
-

Profile

Address
23 Hata'as Street
Kfar Saba JM 44425
Israel
Employees -
Website http://cellect.co
Updated 07/08/2019
Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods.

Financials

View All

Kasbian Nuriel Chirich
Chairman
Shai Yarkoni
Chief Executive Officer & Director